🇺🇸 FDA
Pipeline program

CORT125134 150 mg

CORT125134-453

Phase 1 small_molecule completed

Quick answer

CORT125134 150 mg for Healthy is a Phase 1 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials